NMO SPECTRUM DISORDER

Clinical trials for NMO SPECTRUM DISORDER explained in plain language.

Never miss a new study

Get alerted when new NMO SPECTRUM DISORDER trials appear

Sign up with your email to follow new studies for NMO SPECTRUM DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 1

Immune cell therapy aimed at autoimmune diseases hits early snag

Disease control Terminated

This early-phase trial planned to test a one-time infusion of genetically modified immune cells (CAR-T cells) targeting CD19 in people with several autoimmune diseases, including lupus and multiple sclerosis. The goal was to see if it was safe and could reduce harmful antibodies.…

Matched conditions: NMO SPECTRUM DISORDER

Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:01 UTC

NMO SPECTRUM DISORDER

Get alerted when new NMO SPECTRUM DISORDER trials appear

Immune cell therapy aimed at autoimmune diseases hits early snag